Scopus (CiteScore 2022 =3.0, Q3) , ISC

Document Type : Original Research Article


1 Associate Professor of General Surgery, Faculty of Medicine, AL Azhar University

2 Lecturer of General Surgery, Faculty of Medicine, AL Azhar University

3 Lecturer of Radiology, Faculty of Medicine, AL Azhar University



The purpose of this research was to compare the effects of radiofrequency ablation on early hepatocellular carcinoma (HCC) to those of surgical liver resection in terms of the following outcomes: Intraoperative blood loss as well as transfusion, operation time, respectability time, hospital stay, intensive care unit stay, and postoperative morbidity. Forty individuals diagnosed with a hepatocellular carcinoma were compared on a number of different metrics, including demographic and biochemical make-up, surgical as well as post-operative details, complications, and cost. When compared to the surgical resection group, the radiofrequency ablation group experienced significantly shorter operation, resection, blood loss, transfusion, hospital, and intensive care unit (ICU) stays. In comparison to the surgical resection group, the RFA group had fewer cases of postoperative bleeding, bile leak, and chest infection. We conclude that radiofrequency ablation is preferable to hepatic resection because it reduces the surgery duration, the need for blood transfusions, the length of time spent in the hospital, as well as the number and severity of postoperative problems.

Graphical Abstract

Comparative study amongst surgical resection & radiofrequency in treatment of hepatocellular carcinoma


Main Subjects

[1] (a) S. Chidambaranathan-Reghupaty, P.B. Fisher, D. Sarkar, Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification, Advances in cancer research, 2021, 149, 1-61. [Crossref], [Google Scholar], [Publisher], (b) V.R. Lakshmidevi, D. Reeja, A.R. Rajan, B. Vinod, Advanced spectrum of imidazole derivatives in therapeutics: a review, Journal of Chemical Reviews, 2023, 5, 241-262. [Crossref], [Pdf], [Publisher], (c) S. Asirvatham, E. Thakor, H. Jain, Morpholine and thiomorpholine: a privileged scaffold possessing diverse bioactivity profile, Journal of Chemical Reviews, 2021, 3, 247-272. [Crossref], [Google Scholar], [Publisher], (d) S. Maleki Dizaj, S. Sharifi, S. Shahi, S. Montazersaheb, S. Salatin, E. Ahmadian, K. Khezri, Y. Rahbar Saadat, E. Dalir Abdolahinia, M.A. Ghavimi, The most important consideration in clinical usage of curcumin, Journal of Medicinal and Pharmaceutical Chemistry Research, 2022, 4, 1224-1236. [Pdf], [Publisher], (e) C. Ravipati, S.K. Murthy, Y. Muralidharan, K.K. Ramakrishnan, S. Ramaswamy, P.A. Natarajan,  Comparative study on role of MR chemical shift imaging (mDIXON) and ultrasound elastography with CT hounsfield unit in assessment of early stages of non-acoholic fatty liver disease, Journal of Medicinal and Chemical Sciences, 2023, (In Press), 287-299. [Crossref], [Google Scholar], [Publisher], (f) T. Triyono, I. Adhayanti, U. Sukorini, Risk of increased post-transfusion IL-8 levels in adult patients with malignancy receiving non-leukodepleted packed red cell transfusions, Journal of Medicinal and Chemical Sciences, 2023, 6, 2804-2811. [Crossref], [Pdf], [Publisher]
[2] N.S. Parra, H.M. Ross, A. Khan, M. Wu, R. Goldberg, L. Shah, S. Mukhtar, Beiriger, J. A. Gerber, D. Halegoua-DeMarzio, Advancements in the diagnosis of hepatocellular carcinoma, International Journal of Translational Medicine2023, 3, 51-65. [Crossref], [Google Scholar], [Publisher]
[3] X. Zhang, L. Guan, H. Tian, Z. Zeng, J. Chen, D. Huang, J. Sun, J. Guo, H. Cui, Y. Li, , Risk factors and prevention of viral hepatitis-related hepatocellular carcinoma, Frontiers in oncology2021, 11, 686962. [Crossref], [Google Scholar], [Publisher]
[4] M. Allaire, C. Goumard, C. Lim, A. Le Cleach, M. Wagner, O. Scatton, New frontiers in liver resection for hepatocellular carcinoma,  JHEP Reports, 2020, 2, 100134. [Crossref], [Google Scholar], [Publisher]
[5] A. Perrakis, M. Rahimli, A.A. Gumbs, V. Negrini, M. Andric, J. Stockheim, C. Wex, E. Lorenz, J. Arend, M. Franz, R.S. Croner, Three-device (3D) technique for liver parenchyma dissection in robotic liver surgery, Journal of Clinical Medicine, 2021, 10, p.5265. [Crossref], [Google Scholar], [Publisher]
[6] Z. Chen, H. Xie, M. Hu, T. Huang, Y. Hu, N. Sang, Y. Zhao, Recent progress in treatment of hepatocellular carcinoma, American journal of cancer research2020, 10, 2993. [Google Scholar], [Publisher]
[7] S. Young, J. Golzarian, Locoregional therapies in the treatment of 3-to 5-cm hepatocellular carcinoma: critical review of the literature, American Journal of Roentgenology, 2020215, 223-234. [Crossref], [Google Scholar], [Publisher]
[8] R. Nevola, G. Tortorella, V. Rosato, L. Rinaldi, S. Imbriani, P. Perillo, D. Mastrocinque, M. La Montagna, A. Russo, G. Di Lorenzo, M. Alfano, Gender differences in the pathogenesis and risk factors of hepatocellular carcinoma, Biology2023, 12, 984. [Crossref], [Google Scholar], [Publisher]
[9] T. Taka Yama, K. Hasegawa, N. Izumi, M. Kudo, M. Shimada, N. Yamanaka, M. Inomata, S. Kaneko, H. Nakayama, Y. Kawaguchi, K. Kashiwa bara, Surgery versus radiofrequency ablation for small hepatocellular carcinoma: a randomized controlled trial (SURF trial), Liver Cancer, 2022, 11, 209-218. [Crossref], [Google Scholar], [Publisher]
[10] S. Jin, S. Tan, W. Peng, Y. Jiang, C. Luo, Radiofrequency ablation versus laparoscopic hepatectomy for treatment of hepatocellular carcinoma: a systematic review and meta-analysis, World journal of surgical oncology2020, 18, pp.1-10. [Crossref], [Google Scholar], [Publisher]
[11] K. Wang, R. Wang, S. Liu, G. Peng, H. Yu, X. Wang, Comparison of the safety and efficacy of hepatic resection and radiofrequency ablation in the treatment of single small hepatocellular carcinoma: systematic review and meta-analysis, Translational Cancer Research2022, 11, 580. [Crossref], [Google Scholar], [Publisher]
[12] X. Huang, Y. Liu, L. Xu, T. Ma, X. Yin, Z. Huang, C. Wang, Z. Huang, X. Bi, X. Che, Meta-analysis of Percutaneous vs. Surgical Approaches Radiofrequency Ablation in Hepatocellular Carcinoma, Frontiers in Surgery, 20228, 788771. [Crossref], [Google Scholar], [Publisher]
[13] C.Y. Wei, G.Y. Chau, P.H. Chen, C.A. Liu, Y.H. Huang, T.I. Huo, M.C. Hou, H.C. Lin, Y.H. Su, J.C. Wu, C.W. Su, A comparison of prognoses between surgical resection and radiofrequency ablation therapy for patients with hepatocellular carcinoma and esophagogastric varices, Scientific reports, 202010, 17259. [Crossref], [Google Scholar], [Publisher]
[14] J. Li, H. Wu, K. Qian, Y. Zeng, Contrast enhanced intraoperative ultrasonography-guided radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy through percutaneous or open approach: A retrospective cohort study, Int J Clin Exp Med, 201811, 13365-13373. [Google Scholar], [Publisher]
[15] Y. Xin, X. Zhang, Y. Yang, Y. Chen, Y. Wang, X. Zhou, X. Li, Prediction of late recurrence after radiofrequency ablation of HBV-related hepatocellular carcinoma with the age-male-albumin-bilirubin-platelets (aMAP) risk score: a multicenter study, Journal of Gastrointestinal Oncology, 202112, 2930. [Crossref], [Google Scholar], [Publisher]
[16] H. Kuroda, K. Kasai, K. Kakisaka, Yasumi, Y., Kataoka, K., Ushio, A., Miyamoto, Y., Sawara, K., Oikawa, K., Kondo, K. and Y. Miura, Changes in liver function parameters after percutaneous radiofrequency ablation therapy in patients with hepatocellular carcinoma, Hepatology Research, 201040, 550-554. [Crossref], [Google Scholar], [Publisher]
[17] Y.Y. Yue, W.L. Zhou, Hepatic resection is associated with improved long-term survival compared to radio-frequency ablation in patients with multifocal hepatocellular carcinoma, Frontiers in Oncology, 2020, 10, 110.[Crossref], [Google Scholar], [Publisher]